OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Significant Dose-Response Association of Physical Activity and Diet Quality With Mortality in Adults With Suspected NAFLD in a Population Study
Eduardo Vilar‐Gómez, Raj Vuppalanchi, Samer Gawrieh, et al.
The American Journal of Gastroenterology (2023) Vol. 118, Iss. 9, pp. 1576-1591
Closed Access | Times Cited: 18

Showing 18 citing articles:

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 492-542
Closed Access | Times Cited: 281

Clinical Trial Landscape in NASH
Stephen A. Harrison, Rohit Loomba, Julie Dubourg, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 8, pp. 2001-2014
Closed Access | Times Cited: 74

EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Obesity Facts (2024) Vol. 17, Iss. 4, pp. 374-444
Open Access | Times Cited: 54

PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease
Naga Chalasani, Eduardo Vilar‐Gómez, Rohit Loomba, et al.
Hepatology (2024) Vol. 80, Iss. 5, pp. 1212-1226
Closed Access | Times Cited: 11

Practical Lifestyle Management of Nonalcoholic Fatty Liver Disease for Busy Clinicians
Shira Zelber‐Sagi, J. Bernadette Moore
Diabetes Spectrum (2024) Vol. 37, Iss. 1, pp. 39-47
Open Access | Times Cited: 9

MASLD treatment—a shift in the paradigm is imminent
Mariana Verdelho Machado
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 18

Leisure-Time Physical Activity in Subjects with Metabolic-Dysfunction-Associated Steatotic Liver Disease: An All-Cause Mortality Study
Ritanna Curci, Caterina Bonfiglio, Isabella Franco, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3772-3772
Open Access | Times Cited: 4

PNPLA3 rs738409, environmental factors and liver-related mortality in the U.S. Population
Eduardo Vilar‐Gómez, Samer Gawrieh, Raj Vuppalanchi, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 2

Socioeconomic status and health disparities drive differences in accelerometer-derived physical activity in fatty liver disease and significant fibrosis
Lucia Tabacu, Sajag Swami, Mark K. Ledbetter, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0301774-e0301774
Open Access | Times Cited: 1

Exerkines: Benign adaptation for exercise and benefits for non-alcoholic fatty liver disease
Yang Chen, Yan Zhang, Xingsheng Jin, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 726, pp. 150305-150305
Closed Access

Relationship between diet quality and nonalcoholic fatty liver disease predictor indices in Iranian patients with metabolic syndrome: A cross‐sectional study
Maryam Taghdir, Akram Salehi, Karim Parastouei, et al.
Food Science & Nutrition (2023) Vol. 11, Iss. 10, pp. 6133-6139
Open Access | Times Cited: 1

Low Health Literacy, Lack of Knowledge, and Self-Control Hinder Healthy Lifestyles in Diverse Patients with Steatotic Liver Disease
Gloria Figueroa, Stephanie M. Castañeda, Hayley McLean, et al.
Digestive Diseases and Sciences (2023) Vol. 69, Iss. 2, pp. 384-398
Closed Access

Page 1

Scroll to top